Petros Pharmaceuticals lowers stockholder quorum requirement from majority to one-third

Petros Pharmaceuticals, Inc.

Board approved amendment reducing quorum from majority to one-third of outstanding voting shares.
Amendment effective August 15, 2023, applies to all stockholder meetings and class votes.
Change aims to facilitate conducting business at meetings by lowering the attendance threshold.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Petros Pharmaceuticals, Inc.: Amended Article III, Section 7 of the bylaws to reduce the stockholder quorum requirement from a majority to one-third of outstanding shares (effective 2023-08-15).

Change: bylaw amendment
Effective: 2023-08-15

Exact text from the filing

On August 15, 2023, the board of directors of Petros Pharmaceuticals, Inc. (the “Company”) approved an Amendment (the “Amendment”) to the Company’s Amended and Restated By-laws (the “By-laws”), which became effective as of August 15, 2023.

View on SEC.gov

Browse all governance changes →

Petros Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-092020

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.